Group leader: José Antonio Iribarren, M.D., Ph.D.

Donostialdea IHO joseantonio.iribarrenloyarte@osakidetza.eus

Strategic Objectives

To improve the care provided to our patients through clinical research applied in a sustainable framework.

Lines of research

• HIV
  • Effectiveness and efficiency of antiretroviral therapy (efficiency, virological failure, etc.).
  • New care modals.
  • Morbidity and mortality among the cohort.
  • Access to clinical trials.
• HIV/HVC co-infection
  • Epidemiology.
  • Cirrhosis and its complications following sustained viral response.
• Non-HIV infections
  • Infective endocarditis.
  • Prosthetic joint infection and other musculoskeletal infections.
  • Bacteraemia.
  • Sexually transmitted diseases. Pre-exposure treatment.
  • Access to clinical trials (Clostridium difficile, cellulitis, bacteraemia and other organ infections).
• Non-HIV infections -COVID
  • Descriptive studies in the general population and in subpopulations (immunosuppressed).
  • Clinical prediction rules.
  • Access to clinical trials.
• High-risk infectious diseases and organisation and training in High-Level Hospital Isolation Units (UAAN)